Unitree Robotics Wins Shanghai IPO Approval at $6.2B
Key insights
- Unitree received Shanghai Stock Exchange approval 73 days after filing, an unusually fast timeline for a STAR Market IPO.
- Humanoid robots now represent 51.5% of Unitree's revenue, having overtaken its original quadruped robot business.
- Unitree shipped more humanoid robots globally than any other company in 2025, establishing clear market leadership before going public.
Why this matters
Unitree's listing would create the first liquid public-market valuation for a humanoid robotics company in China, giving the entire sector a pricing benchmark that venture and growth investors globally will reference. The 73-day regulatory approval speed signals that Chinese authorities are actively compressing the capital formation timeline for domestic robotics firms, which could structurally disadvantage Western competitors who face slower fundraising cycles. For AI and robotics practitioners, a company that already leads global humanoid shipments going public at $6.2 billion reframes the competitive landscape from theoretical parity to validated commercial scale on the Chinese side.
Summary
Unitree Robotics cleared the most critical regulatory step in its IPO process on June 1, winning approval from Shanghai Stock Exchange's Listing Review Committee just 73 days after formally filing.
The company is targeting 4.2 billion yuan ($608M) on the STAR Market at a $6.2 billion valuation. Humanoid robots have overtaken Unitree's original quadruped product line, now accounting for 51.5% of revenue, backed by the highest global humanoid shipment volume in 2025.
Essentially: Unitree Robotics is positioning itself as the first public pricing anchor for China's humanoid robot industry.
- 73-day approval timeline is unusually fast by STAR Market standards.
- Humanoid revenue crossed 51.5% of total sales, a structural pivot away from quadrupeds.
- The $6.2B valuation would set a public benchmark for the entire humanoid sector.
A completed listing gives China's humanoid robot wave its first liquid market reference point, accelerating capital formation for every competing domestic firm that follows.
Potential risks and opportunities
Risks
- If STAR Market sentiment deteriorates before the final listing window closes, a valuation markdown on Unitree's debut could suppress fundraising multiples for the entire humanoid sector for 12-plus months
- Revenue concentration risk is real: with humanoids at 51.5% of sales and quadrupeds declining, any softening in enterprise or government humanoid demand in H2 2026 directly hits IPO-year financials under public scrutiny
- Western humanoid firms (Figure AI, Boston Dynamics, Apptronik) and their investors face accelerated fundraising pressure as Unitree's public listing validates a higher valuation ceiling that they will be measured against
Opportunities
- Chinese component suppliers in the humanoid supply chain, including actuator, sensor, and compute vendors, gain a credible valuation comp and increased leverage for contract renegotiation and their own potential listings
- Competing humanoid firms outside China (Figure AI, Apptronik, 1X Technologies) can use Unitree's public market valuation as a defensible anchor in their next funding rounds, likely in the next 6-12 months
- Global robotics ETF managers and index funds face inclusion pressure once Unitree lists, creating forced-buyer demand dynamics in the first 60-90 days post-IPO that benefit early position holders
What we don't know yet
- Whether the final IPO pricing will hold the $6.2B valuation given STAR Market hardware-sector volatility observed since Q1 2026
- Gross margin breakdown between humanoid and quadruped product lines, not disclosed in public filings reviewed so far
- Which institutional investors anchored the pre-IPO book and at what cap table terms, not yet confirmed in regulatory documents
Originally reported by scmp.com
Read the original article →Original headline: Unitree Clears Key Hurdle to Shanghai IPO as China's Humanoid Robot Wave Gathers Pace